For research use only. Not for therapeutic Use.
Pirarubicin Hydrochloride（Cat No.:I005654）is an anthracycline chemotherapy agent used primarily in the treatment of various cancers, including leukemia and solid tumors. As a derivative of doxorubicin, it exerts its antitumor effects by intercalating into DNA and inhibiting topoisomerase II, disrupting DNA replication and RNA synthesis. This compound is known for its ability to induce apoptosis in cancer cells. Its hydrochloride form enhances solubility and stability, facilitating administration in clinical settings. Ongoing research continues to explore its efficacy and potential in combination therapies, improving outcomes for cancer patients.
| Catalog Number | I005654 |
| CAS Number | 95343-20-7 |
| Molecular Formula | C32H37NO12HCl |
| Purity | ≥95% |
| Target | Topoisomerase |
| Solubility | 10 mM in DMSO |
| Storage | 3 years -20C powder |
| Reference | <p style=/line-height:25px/> |
